| License: Creative Commons Attribution 4.0 PDF - Published Version (3MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-514645
- DOI to cite this document:
- 10.5283/epub.51464
Abstract
Cold Atmospheric Plasma (CAP) has shown promising results in the treatment of various skin diseases. The therapeutic effect of CAP on localized scleroderma (LS), however, has not yet been evaluated. We investigated the effects of CAP on LS by comparing human normal fibroblasts (hNF), human TGF-beta-activated fibroblasts (hAF), and human localized scleroderma-derived fibroblasts (hLSF) after ...
Owner only: item control page